KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsReceivables RefundsShares Repurchased
Ratios

Takeda Pharmaceutical (TAK) Accumulated Depreciation & Amortization (2017 - 2018)

Historic Accumulated Depreciation & Amortization for Takeda Pharmaceutical (TAK) over the last 2 years, with Q4 2018 value amounting to $2.3 billion.

  • Takeda Pharmaceutical's Accumulated Depreciation & Amortization rose 7503.06% to $2.3 billion in Q4 2018 from the same period last year, while for Dec 2018 it was $2.3 billion, marking a year-over-year increase of 7503.06%. This contributed to the annual value of $1.1 billion for FY2018, which is 1425.96% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Accumulated Depreciation & Amortization of $2.3 billion as of Q4 2018, which was up 7503.06% from $1.3 billion recorded in Q4 2017.
  • Takeda Pharmaceutical's 5-year Accumulated Depreciation & Amortization high stood at $2.3 billion for Q4 2018, and its period low was $1.3 billion during Q4 2017.